13S107: Abstracts: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science (0574–0577)

Abstract Moderator(s)

• 

  Karla Miller, MD

  University of Utah School of Medicine
  Salt Lake City, UT, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose
• 

  Katherine Wysham, MD

  VA PUGET SOUND/UNIVERSITY OF WASHINGTON
  Seattle, WA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 8:00 AM – 8:10 AM Eastern Time

  Osteoporosis in Elderly Men; An Underestimated and Underdiagnosed Morbid Entity
  

  Presenting Author: Arash Mollaeian, MD – Metro Health Medical Center/Case Western Reserve University, department of rheumatology
• 8:10 AM – 8:15 AM Eastern Time

  Q&A
  
• 8:15 AM – 8:25 AM Eastern Time

  Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment with Denosumab or Zoledronic Acid for Osteoporosis
  

  Presenting Author: Leslie Spangler, PhD, DVM – Amgen, Inc.
• 8:25 AM – 8:30 AM Eastern Time

  Q&A
  
• 8:30 AM – 8:40 AM Eastern Time

  Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (U.S.)
  

  Presenting Author: Min Kim, PhD, MPH – Amgen, Inc.
• 8:40 AM – 8:45 AM Eastern Time

  Q&A
  
• 8:45 AM – 8:55 AM Eastern Time

  Bone Mineral Density of Radius 1/3 Led to a Better Fracture Prediction When Combined with Spine but Not Hip BMD: Results from the São Paulo Ageing & Health (SPAH) Study
  

  Presenting Author: Diogo Domiciano, MD, PhD – Hospital das Clinicas, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo
• 8:55 AM – 9:00 AM Eastern Time

  Q&A